Norwegian health service should offer stem cell therapy for multiple sclerosis

Gro Owren Nygaard; Trygve Holmøy

doi:10.4045/tidsskr.23.0770

Norwegian health service should offer stem cell therapy for multiple sclerosis

Tidsskr Nor Laegeforen. 2024 Feb 7;144(2). doi: 10.4045/tidsskr.23.0770. Print 2024 Feb 13.

[Article in English, Norwegian]

Authors

Gro Owren Nygaard, Trygve Holmøy

PMID: 38349100
DOI: 10.4045/tidsskr.23.0770

No abstract available

Plain language summary

Many Norwegian patients with multiple sclerosis choose to travel abroad for stem cell therapy at their own expense and risk. Based on the current knowledge base, selected patients should now be offered this therapy in Norway.

MeSH terms

Cell- and Tissue-Based Therapy
Health Services
Humans
Multiple Sclerosis* / therapy
Norway